had previously been implicated in chemokine receptor signaling in both T and B cells9C12. cell frequency, and an indirect effect on B cell migration and germinal center formation. Notably, several recent publications described an increase in circulating TFH cells GSK6853 in patients with type 1 diabetes, suggesting this cell population is involved in pathogenesis. Though KD was insufficient to alter diabetes frequency in the NOD model, our findings raise the possibility that plays a role in autoimmunity owing to its function in TFH cells. This mechanistic link, while speculative at this time, would lend support to the notion that TFH cells are key participants in autoimmunity and could explain association with several GSK6853 immune-mediated diseases. INTRODUCTION region with multiple sclerosis and celiac disease2,3 (P < 10?17), and a suggestive association with type 1 diabetes4,5. RGS proteins are GTPase activating proteins that modulate chemokine receptor signaling1. Chemokine receptors depend on heterotrimeric G-proteins to activate downstream effectors6. Upon ligand activation, the G-protein alpha subunit (G) exchanges GTP for GDP, resulting in dissociation from the G heterodimer7 and initiating signaling cascades that lead to cytoskeletal rearrangements and cell migration. Hydrolysis of GTP by Gs intrinsic GTPase activity causes signal termination. This enzymatic activity is accelerated by RGS-family proteins1. is highly expressed in lymphoid organs and serves as a negative regulator of chemokine receptor signaling in lymphocytes1,8. Ablation of in mice was shown to modify B cell trafficking9. In GSK6853 addition, deficiency leads to aberrant architecture of germinal centers9C11. Although the phenotype described for knockout (KO) mice was largely attributed to B cell dysfunction, a subsequent study found that also participates in chemotactic signaling in T cells12. thus affects the migratory behavior of multiple cell types, and it is as yet unclear how gene variation modifies the risk of autoimmunity, and of type 1 diabetes in particular. T follicular helper cells (TFH) reside in the follicular areas of secondary lymphoid organs where they promote B cells expansion and antibody affinity maturation within germinal centers13. TFH maturation is a multistep process that begins in the T cell zone with the activation of naive CD4+ T lymphocytes and leads to expression of the transcription factorBcl6drives the expression of the chemokine receptor CXCR5 that promotes migration from the T cell zone towards the B cell follicle14. This migration also requires downregulation of CCR7 signaling15. Of interest, expression is markedly up-regulated in TFH cells16, and this likely contributes to desensitizing migrating cells to CCR7 ligands. Notably, several studies have recently implicated TFH cells in type 1 diabetes17C19. The frequency of TFH cells was found to be elevated in patients with type 1 diabetes. A similar increase in TFH cells was observed in a mouse model for autoimmune diabetes19. To investigate a possible role for in autoimmunity, we developed inducible knockdown (KD) mice within the nonobese diabetic (NOD) mouse model for type 1 diabetes20. silencing recapitulated key phenotypes described for KO mice9, including increased lymphocyte chemotaxis and enlarged germinal centers. While we found that KD did not alter the risk of diabetes in NOD mice, we observed that loss of reduced the frequency of TFH cells. Furthermore, KD in T cells was sufficient to modify the migration of B cells. These findings suggest that the effects of KO on germinal center formation described previously may be caused in part by changes in TFH cell function. In addition, our data suggest that upregulation is a critical step in the migration of TFH cells that enables cells to downregulate CCR7 signals and to migrate into the follicular area. A link between expression and TFH cell GSK6853 frequency, a T cell subset implicated in type 1 diabetes, could explain the association of variants with autoimmunity. RESULTS Generation of Rgs1 knockdown NOD mice To study the role of in autoimmune diabetes, we generated transgenic nonobese diabetic (NOD) mice in which gene expression can be silenced by RNAi in a doxycycline-dependent manner21. We first validated lentiviral constructs for KD luciferase reporter where cDNA is incorporated into the 3 UTR of the luciferase gene. We transfected the luciferase reporter into HEK293 cells transduced with lentivirus encoding different shRNA sequences against luciferase activity as a measure of gene knockdown. We identified two shRNA sequences that potently inhibited the luciferase reporter (Fig. 1a). These shRNA sequences were further validated for their ability to silence expression of a FLAG-tagged construct, as measured by quantitative PCR (Fig. 1b) and western blotting (Fig. 1c and 1d). The selected shRNA sequences were then used to generate two distinct KD NOD lines by lentiviral transgenesis (Fig. 1e and supplementary Fig. S1). Finally, we confirmed that doxycycline treatment (100 g/ml in the GP1BA drinking water for two weeks) induced KD (Fig. 1fC1h,.